|
1
|
Evron T, Daigle TL, Caron MG, Rivas V,
Nogués L, Lucas E, Vila-Bedmar R, Murga C and Mayor F Jr: GRK2:
multiple roles beyond G protein-coupled receptor desensitization.
Trends Pharmacol Sci. 33:154–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Penela P, Murga C, Ribas C, Lafarga V and
Mayor F Jr: The complex G protein-coupled receptor kinase 2 (GRK2)
interactome unveils new physiopathological targets. Br J Pharmacol.
160:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cannavo A, Liccardo D and Koch WJ:
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for
heart failure therapy. Front Physiol. 4:2642013. View Article : Google Scholar
|
|
4
|
Piao L, Fang YH, Parikh KS, Ryan JJ,
D'Souza KM, Theccanat T, Toth PT, Pogoriler J, Paul J, Blaxall BC,
et al: GRK2-mediated inhibition of adrenergic and dopaminergic
signaling in right ventricular hypertrophy: therapeutic
implications in pulmonary hypertension. Circulation. 126:2859–2869.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elorza A, Sarnago S and Mayor F Jr:
Agonist-dependent modulation of G protein-coupled receptor kinase 2
by mitogen-activated protein kinases. Mol Pharmacol. 57:778–783.
2000.PubMed/NCBI
|
|
6
|
Whalen EJ, Foster MW, Matsumoto A, Ozawa
K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, et
al: Regulation of β-adrenergic receptor signaling by
S-nitrosylation of G-protein-coupled receptor kinase 2. Cell.
129:511–522. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eichmann T, Lorenz K, Hoffmann M,
Brockmann J, Krasel C, Lohse MJ and Quitterer U: The amino-terminal
domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta
gamma binding site. J Biol Chem. 278:8052–8057. 2003. View Article : Google Scholar
|
|
8
|
Houslay MD and Baillie GS:
Phosphodiesterase-4 gates the ability of protein kinase A to
phosphorylate G-protein receptor kinase-2 and influences its
translocation. Biochem Soc Trans. 34:474–475. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Granier S, Kim S, Shafer AM, Ratnala VR,
Fung JJ, Zare RN and Kobilka B: Structure and conformational
changes in the C-terminal domain of the β2-adrenoceptor:
insights from fluorescence resonance energy transfer studies. J
Biol Chem. 282:13895–13905. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reiter E and Lefkowitz RJ: GRKs and
β-arrestins: roles in receptor silencing, trafficking and
signaling. Trends Endocrinol Metab. 17:159–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nobles KN, Xiao K, Ahn S, Shukla AK, Lam
CM, Rajagopal S, Strachan RT, Huang TY, Bressler EA, Hara MR, et
al: Distinct phosphorylation sites on the β(2)-adrenergic receptor
establish a barcode that encodes differential functions of
β-arrestin. Sci Signal. 4:ra512011. View Article : Google Scholar
|
|
12
|
de Gasparo M, Catt KJ, Inagami T, Wright
JW and Unger T: International union of pharmacology. XXIII. The
angiotensin II receptors. Pharmacol Rev. 52:415–472.
2000.PubMed/NCBI
|
|
13
|
Violin JD, Dewire SM, Barnes WG and
Lefkowitz RJ: G protein-coupled receptor kinase and
beta-arrestin-mediated desensitization of the angiotensin II type
1A receptor elucidated by diacylglycerol dynamics. J Biol Chem.
281:36411–36419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rajagopal K, Whalen EJ, Violin JD, Stiber
JA, Rosenberg PB, Premont RT, Coffman TM, Rockman HA and Lefkowitz
RJ: Beta-arrestin2-mediated inotropic effects of the angiotensin II
type 1A receptor in isolated cardiac myocytes. Proc Natl Acad Sci
USA. 103:16284–16289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kleibeuker W, Jurado-Pueyo M, Murga C,
Eijkelkamp N, Mayor F Jr, Heijnen CJ and Kavelaars A: Physiological
changes in GRK2 regulate CCL2-induced signaling to ERK1/2 and Akt
but not to MEK1/2 and calcium. J Neurochem. 104:979–992. 2008.
View Article : Google Scholar
|
|
16
|
Lipfert J, Ödemis V and Engele J: Grk2 is
an essential regulator of CXCR7 signalling in astrocytes. Cell Mol
Neurobiol. 33:111–118. 2013. View Article : Google Scholar
|
|
17
|
Neuschäfer-Rube F, Oppermann M, Möller U,
Böer U and Püschel GP: Agonist-induced phosphorylation by G
protein-coupled receptor kinases of the EP4 receptor
carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor
hybrid. Mol Pharmacol. 56:419–428. 1999.PubMed/NCBI
|
|
18
|
Wang Y, Gao E, Lau WB, Wang Y, Liu G, Li
JJ, Wang X, Yuan Y, Koch WJ and Ma XL: G-protein-coupled receptor
kinase 2-mediated desensitization of adiponectin receptor 1 in
failing heart. Circulation. 131:1392–1404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kelley-Hickie LP and Kinsella BT:
Homologous desensitization of signalling by the beta (beta) isoform
of the human thromboxane A2 receptor. Biochim Biophys Acta.
1761:1114–1131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanaide M, Uezono Y, Matsumoto M, Hojo M,
Ando Y, Sudo Y, Sumikawa K and Taniyama K: Desensitization of
GABA(B) receptor signaling by formation of protein complexes of
GABA(B2) subunit with GRK4 or GRK5. J Cell Physiol. 210:237–245.
2007. View Article : Google Scholar
|
|
21
|
Terunuma M, Pangalos MN and Moss SJ:
Functional modulation of GABAB receptors by protein kinases and
receptor trafficking. Adv Pharmacol. 58:113–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iacovelli L, Capobianco L, D'Ancona GM,
Picascia A and De Blasi A: Regulation of lysophosphatidic acid
receptor-stimulated response by G-protein-coupled receptor kinase-2
and beta-arrestin1 in FRTL-5 rat thyroid cells. J Endocrinol.
174:103–110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho DI, Zheng M, Min C, Kwon KJ, Shin CY,
Choi HK and Kim KM: ARF6 and GASP-1 are post-endocytic sorting
proteins selectively involved in the intracellular trafficking of
dopamine D2 receptors mediated by GRK and PKC in
transfected cells. Br J Pharmacol. 168:1355–1374. 2013. View Article : Google Scholar :
|
|
24
|
Namkung Y, Dipace C, Urizar E, Javitch JA
and Sibley DR: G protein-coupled receptor kinase-2 constitutively
regulates D2 dopamine receptor expression and signaling
independently of receptor phosphorylation. J Biol Chem.
284:34103–34115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Sasai N, Ma G, Yue T, Jia J,
Briscoe J and Jiang J: Sonic Hedgehog dependent phosphorylation by
CK1α and GRK2 is required for ciliary accumulation and activation
of smoothened. PLoS Biol. 9:e10010832011. View Article : Google Scholar
|
|
26
|
Evron T, Philipp M, Lu J, Meloni AR,
Burkhalter M, Chen W and Caron MG: Growth Arrest Specific 8 (Gas8)
and G protein-coupled receptor kinase 2 (GRK2) cooperate in the
control of Smoothened signaling. J Biol Chem. 286:27676–27686.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peppel K, Jacobson A, Huang X, Murray JP,
Oppermann M and Freedman NJ: Overexpression of G protein-coupled
receptor kinase-2 in smooth muscle cells attenuates mitogenic
signaling via G protein-coupled and platelet-derived growth factor
receptors. Circulation. 102:793–799. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei Z, Hurtt R, Gu T, Bodzin AS, Koch WJ
and Doria C: GRK2 negatively regulates IGF-1R signaling pathway and
cyclins' expression in HepG2 cells. J Cell Physiol. 228:1897–1901.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng H, Worrall C, Shen H, Issad T,
Seregard S, Girnita A and Girnita L: Selective recruitment of G
protein-coupled receptor kinases (GRKs) controls signaling of the
insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA.
109:7055–7060. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
So CH, Michal A, Komolov KE, Luo J and
Benovic JL: G protein-coupled receptor kinase 2 (GRK2) is localized
to centrosomes and mediates epidermal growth factor-promoted
centrosomal separation. Mol Biol Cell. 24:2795–2806. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang ZM, Gao E, Chuprun JK and Koch WJ:
GRK2 in the heart: a GPCR kinase and beyond. Antioxid Redox Signal.
21:2032–2043. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rengo G, Pagano G, Paolillo S, de Lucia C,
Femminella GD, Liccardo D, Cannavo A, Formisano R, Petraglia L,
Komici K, et al: Impact of diabetes mellitus on lymphocyte GRK2
protein levels in patients with heart failure. Eur J Clin Invest.
45:187–195. 2015. View Article : Google Scholar
|
|
33
|
Dorn GW II: GRK mythology: G-protein
receptor kinases in cardiovascular disease. J Mol Med Berl.
87:455–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rengo G, Perrone-Filardi P, Femminella GD,
Liccardo D, Zincarelli C, de Lucia C, Pagano G, Marsico F,
Lymperopoulos A and Leosco D: Targeting the β-adrenergic receptor
system through G-protein-coupled receptor kinase 2: a new paradigm
for therapy and prognostic evaluation in heart failure: from bench
to bedside. Circ Heart Fail. 5:385–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Homan KT, Wu E, Wilson MW, Singh P, Larsen
SD and Tesmer JJ: Structural and functional analysis of g
protein-coupled receptor kinase inhibition by paroxetine and a
rationally designed analog. Mol Pharmacol. 85:237–248. 2014.
View Article : Google Scholar :
|
|
36
|
Schumacher SM, Gao E, Zhu W, Chen X,
Chuprun JK, Feldman AM, Tesmer JJ and Koch WJ: Paroxetine-mediated
GRK2 inhibition reverses cardiac dysfunction and remodeling after
myocardial infarction. Sci Transl Med. 7:277ra312015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thal DM, Homan KT, Chen J, Wu EK, Hinkle
PM, Huang ZM, Chuprun JK, Song J, Gao E, Cheung JY, et al:
Paroxetine is a direct inhibitor of g protein-coupled receptor
kinase 2 and increases myocardial contractility. ACS Chem Biol.
7:1830–1839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Santulli G, Trimarco B and Iaccarino G:
G-protein-coupled receptor kinase 2 and hypertension: molecular
insights and pathophysiological mechanisms. High Blood Press
Cardiovasc Prev. 20:5–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eckhart AD, Ozaki T, Tevaearai H, Rockman
HA and Koch WJ: Vascular-targeted overexpression of G
protein-coupled receptor kinase-2 in transgenic mice attenuates
beta-adrenergic receptor signaling and increases resting blood
pressure. Mol Pharmacol. 61:749–758. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Erbel R, Lehmann N, Möhlenkamp S,
Churzidse S, Bauer M, Kälsch H, Schmermund A, Moebus S, Stang A,
Roggenbuck U, et al: Heinz Nixdorf Recall Study Investigators:
Subclinical coronary atherosclerosis predicts cardiovascular risk
in different stages of hypertension: result of the Heinz Nixdorf
Recall Study. Hypertension. 59:44–53. 2012. View Article : Google Scholar
|
|
41
|
Bax M, van Heemst J, Huizinga TW and Toes
RE: Genetics of rheumatoid arthritis: What have we learned?
Immunogenetics. 63:459–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen JY, Wu HX, Chen Y, Zhang LL, Wang QT,
Sun WY and Wei W: Paeoniflorin inhibits proliferation of
fibroblast-like synoviocytes through suppressing G-protein-coupled
receptor kinase 2. Planta Med. 78:665–671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nelson PT, Braak H and Markesbery WR:
Neuropathology and cognitive impairment in Alzheimer disease: a
complex but coherent relationship. J Neuropathol Exp Neurol.
68:1–14. 2009. View Article : Google Scholar :
|
|
45
|
Obrenovich ME, Smith MA, Siedlak SL, Chen
SG, de la Torre JC, Perry G and Aliev G: Overexpression of GRK2 in
Alzheimer disease and in a chronic hypoperfusion rat model is an
early marker of brain mitochondrial lesions. Neurotox Res.
10:43–56. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Obrenovich ME, Morales LA, Cobb CJ, Shenk
JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G and Aliev
G: Insights into cerebrovascular complications and Alzheimer
disease through the selective loss of GRK2 regulation. J Cell Mol
Med. 13:853–865. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Suo WZ and Li L: Dysfunction of G
protein-coupled receptor kinases in Alzheimer's disease.
ScientificWorldJournal. 10:1667–1678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wei Z, Hurtt R, Ciccarelli M, Koch WJ and
Doria C: Growth inhibition of human hepatocellular carcinoma cells
by over-expression of G-protein-coupled receptor kinase 2. J Cell
Physiol. 227:2371–2377. 2012. View Article : Google Scholar
|
|
49
|
Penela P, Ribas C and Mayor F Jr:
Mechanisms of regulation of the expression and function of G
protein-coupled receptor kinases. Cell Signal. 15:973–981. 2003.
View Article : Google Scholar : PubMed/NCBI
|
